Research progress in treatment of osteoarthritis targeting subchondral bone sclerosis

何昌军,黄王利,郝博,李庆达,许鹏,杨明义,任小宇,苏亚妮,马尧,许珂
DOI: https://doi.org/10.3877/cma.j.issn.1674-134X.2021.02.012
2021-01-01
Abstract:Osteoarthritis (OA) is a joint degenerative disease characterized by articular cartilage degeneration and subchondral osteosclerosis. The pathological features were articular cartilage degeneration and destruction, subchondral osteosclerosis or cystic change, articular marginal hyperosteogeny, synovial lesions, articular capsule contracture, ligament relaxation or contracture, muscle atrophy and weakness, etc. In recent years, studies have found that subchondral osteosclerosis is a cause of OA, and subchondral osteosclerosis is superior to and accelerates the degeneration of cartilage, thus accelerating the development of OA. It is of great significance to inhibit or delay subchondral osteosclerosis in the treatment of OA. This article reviewed the research progress of OA treatment with subchondral bone sclerosis as the target, and provides help for follow-up basic research and clinical work.
What problem does this paper attempt to address?